Cellular Pathology Referrals - CPP Facilities

" This contract falls within the medical laboratory services category, classified under CPV code 85145000, and is specifically targeted for implementation in the UK region. The procurement stage has progressed to the contract award, which was concluded on 1st August 2025. This contract, currently valued at £3000, is scheduled for services spanning from 1st April 2025 to 31st March 2028.

The procurement was conducted through a direct award process under the Provider Selection Regime (PSR) Regulations 2023, bypassing traditional competitive tendering processes, which aligns with the PSR's specific regulatory framework. Key updates from the tender indicate the procurement method was limited and did not involve prior publication of a call for competition. This tender provides substantial opportunities for businesses in the medical and health sectors, particularly those specialising in UKAS-accredited laboratory services.

Given the direct awarding nature, businesses with expertise in cellular pathology and capabilities to meet clinical interpretation and turnaround requirements as per RCPath guidelines could find ample opportunity for collaboration and growth through this contract. The focus on established regional referral pathways and compliance with genomic hub guidelines further highlights opportunities for laboratories with specialisation in genetic testing. Large scale providers such as CPP Facilities LLP, who are already involved in this award, exemplify the profile of businesses well-suited to compete in such high-stake, direct award procurements.